S$0.002 close for 1H3.SI Clearbridge Health (SES) on 05 Feb 2026: volume jump signals trader focus

Clearbridge Health Limited (1H3.SI) closed at S$0.002 on 05 Feb 2026 in the Singapore (SES) market after a heavy session of 31,140,400 shares traded. The session put 1H3.SI stock among the most active on SES as volume ran roughly 3.12x its 30-day average. Price action was narrow — intraday range S$0.001–S$0.002 — but the high turnover matters for small-cap liquidity and short-term price discovery. Traders should note the company’s next earnings date of 27 Feb 2026, which could drive fresh flows into the stock.

Trading snapshot for 1H3.SI stock

Clearbridge Health (1H3.SI) ended the session at S$0.002 on SES with 31,140,400 shares changing hands. The stock opened at S$0.002, matched the previous close, and traded between S$0.001 and S$0.002 today. Year range sits at S$0.001–S$0.005, market cap is S$8,591,642.00, and shares outstanding are 4,295,820,825. Average daily volume is 9,988,674, so today’s activity put 1H3.SI stock into the most active list for the session.

Why the session made 1H3.SI stock most active

Volume jumped because institutional or retail blocks cleared at penny levels, lifting turnover despite little net price change. Today’s volume of 31,140,400 is 3.12x the average, improving liquidity for a micro-cap. High turnover with a flat close indicates balanced buy and sell interest and raises the chance of larger moves ahead of earnings. For traders, activity rather than directional conviction was the main driver behind 1H3.SI stock today.

Financials and valuation for 1H3.SI stock

Clearbridge reports a mixed set of fundamentals. Key ratios: P/B 0.27, P/S 1.16, and negative trailing earnings (P/E not meaningful). Revenue per share is S$0.005 (rounded) while net income per share is negative. The company shows current ratio 1.73 and debt-to-equity 0.12, suggesting modest leverage. Investors should note thin margins and negative ROE of -19.95%, which underline earnings risk despite a low book-value valuation.

Technical view and sector context for 1H3.SI stock

Technically, 1H3.SI stock has an RSI near 51.74, a short-term average around S$0.002, and ADX at 66.13 indicating a strong trend in trade intensity rather than price direction. The 50-day average (~S$0.002) sits below the 200-day average (~S$0.003), showing mixed momentum. In the Singapore healthcare sector, peers show stronger profit metrics; Clearbridge’s higher turnover today contrasts with the sector’s modest YTD movement and highlights stock-specific flows.

Meyka AI rates 1H3.SI with a score out of 100 and forecast for 1H3.SI stock

Meyka AI rates 1H3.SI with a score out of 100: 57.64/100 — Grade C+ (HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a yearly target of S$0.009 versus the current S$0.002, implying an upside of 350.00%. Forecasts are model-based projections and not guarantees. The grade reflects modest valuation support (P/B low) offset by negative earnings and liquidity risk.

Risks and catalysts for 1H3.SI stock

Key risks: low free cash flow per share, negative operating margins, small market cap (S$8.59M), and thin public float that can magnify moves. Catalysts include the upcoming earnings announcement on 27 Feb 2026, potential strategic investments updates, and any contract wins in imaging or clinics. Given negative ROE and erratic historical returns (1Y change -50.00%), risk management and position sizing are essential for 1H3.SI stock investors.

Final Thoughts

Today’s session placed Clearbridge Health (1H3.SI) among the most active stocks on SES because high turnover improved liquidity at a micro-cap price of S$0.002. Trading interest matters for small-cap discovery, but fundamentals remain mixed: P/B 0.27, negative ROE and limited free cash flow. Meyka AI’s forecast model projects S$0.009 over one year, implying an upside of 350.00% versus the current price, while the proprietary grade sits at 57.64/100 (C+ HOLD). That outlook highlights a contrast: cheap book valuation against earnings and liquidity risk. Investors should watch the 27 Feb 2026 earnings update and sector developments in healthcare. Forecasts are model-based projections and not guarantees. Meyka AI, an AI-powered market analysis platform, flags 1H3.SI stock as a speculative play where event-driven moves and tight risk controls will matter most.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.